Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Leading five global vaccine products by revenue 2017 and 2024

Top 5 global vaccine products based on revenue in 2017 and 2024 (in million U.S. dollars)

by Matej Mikulic, last edited Jul 22, 2019
Leading five global vaccine products by revenue 2017 and 2024 This statistic displays the top 5 global vaccine products based on their revenues worldwide in 2017, and a projection for 2024. Pfizer's pneumococcal vaccine, Prevnar 13, is expected to generate some 5.76 billion U.S. dollars in revenues by 2024. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.
Top vaccine products

Vaccines act as a preventive measure to improve immunity to certain diseases. Often, vaccines are created from a weakened or killed form of a microbe which allows the immune system to react and create a record of it, so that in the future, it can easily recognize these microorganisms. Vaccine use can easily help to prevent contraction of certain viruses such as influenza. However, some countries may not have easy access to vaccinations. In India, there were approximately 1.8 million deaths due to vaccine-preventable diseases as of 2013.

The global vaccination market generated 27.7 billion U.S. dollars in 2017 and is projected to total around 45 billion U.S. dollars in 2024. As of 2014, there were 18 new vaccines that were moving along the research and development pipeline for neglected diseases. Vaccines in the United States accumulated some of the world’s largest revenues, totaling 10.8 billion U.S. dollars in 2013. In comparison, Germany generated around three billion U.S. dollars at the vaccine market. Prevnar 13 and Gardasil are the top vaccines in the world, generating 5.7 billion and 2.4 billion U.S. dollars, respectively, in 2017. Prevnar 13 is marketed by Pfizer and Daewoong.
Show more

Top 5 global vaccine products based on revenue in 2017 and 2024 (in million U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
Top pharmaceutical drugs
Top pharmaceutical drugs

All Information
in one Presentation

Top pharmaceutical drugs

Everything On "Top pharmaceutical drugs" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Vaccinations in the U.S."
  • Global overview
The most important statistics
  • U.S. vaccination impact
  • Children and adolescents
  • Adults
  • Injury and death from vaccines
  • Public opinion
  • Focus: Human papillomavirus (HPV)
  • Miscellaneous
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.